# Abaloparatide ACTIVExtend: fracture risk with alendronate

Source: https://pepvault.app/research/abaloparatide-activextend-2018

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Abaloparatide](https://pepvault.app/research#abaloparatide)

Randomized trial · people

# Abaloparatide then alendronate: 84% lower vertebral fracture risk

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In postmenopausal women, 18 months of abaloparatide followed by alendronate kept fracture risk lower and kept building bone density compared with alendronate after placebo.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2018
- **Journal:** J Clin Endocrinol Metab

## What they tested

The team tested whether 24 months of alendronate after 18 months of abaloparatide lowers fracture risk and builds bone density more than alendronate after 18 months of placebo in postmenopausal women with osteoporosis.

## How the study was done

A follow-on to the placebo-controlled ACTIVE trial. Women who finished ACTIVE on abaloparatide or placebo could take up to 24 months of alendronate, and 92% of those completers enrolled. Fractures and bone mineral density (BMD, a measure of bone strength on a scan) were tracked across the full 43 months.

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Across the full 43 months, 0.9% of women in the abaloparatide-then-alendronate group had a new vertebral (spine) fracture on X-ray, vs 5.6% in the placebo-then-alendronate group. That is an 84% relative risk reduction (P < 0.001). Rates of the other fracture types were also lower in the abaloparatide group (all P < 0.05), BMD gains from the first 18 months kept rising during the alendronate phase, and in the alendronate phase alone vertebral fracture risk was 87% lower (P = 0.001). A separate analysis found no hip fractures in the abaloparatide group while the placebo group had some, and side effects were similar between groups.

## What it doesn’t show

Only women who finished the first trial joined, and the study compared two sequences rather than abaloparatide against alendronate alone. All participants were postmenopausal women, so it does not speak to men or other groups.

## The paper

Bone et al. ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis. J Clin Endocrinol Metab. 2018.

- [PubMed (PMID 29800372)](https://pubmed.ncbi.nlm.nih.gov/29800372/)
- [The paper (DOI 10.1210/jc.2018-00163)](https://doi.org/10.1210/jc.2018-00163)
- [ClinicalTrials.gov (NCT01657162)](https://clinicaltrials.gov/study/NCT01657162)

## The compound

- [Abaloparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Abaloparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024) Randomized trial · people · 2024
- [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023) Randomized trial · people · 2023
- [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017) Randomized trial · people · 2017
- [Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE](https://pepvault.app/research/abaloparatide-active-2016) Randomized trial · people · 2016
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

## The library

- [Abaloparatide](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
